LIFE09200604007 Tabish - Homi Bhabha National Institute

Bibliography
cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinumbased
chemotherapy. Clin Cancer Res 2011, 17, (17), 5801-11.
60. Kennedy, D. O.; Agrawal, M.; Shen, J.; Terry, M. B.; Zhang, F. F.; Senie, R. T.; Motykiewicz, G.;
Santella, R. M., DNA repair capacity of lymphoblastoid cell lines from sisters discordant for
breast cancer. J Natl Cancer Inst 2005, 97, (2), 127-32.
61. Motykiewicz, G.; Faraglia, B.; Wang, L. W.; Terry, M. B.; Senie, R. T.; Santella, R. M., Removal
of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in
lymphoblastoid cell lines from sisters discordant for breast cancer. Environ Mol Mutagen 2002,
40, (2), 93-100.
62. Sturgis, E. M.; Clayman, G. L.; Guan, Y.; Guo, Z.; Wei, Q., DNA repair in lymphoblastoid cell
lines from patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1999, 125, (2),
185-90.
63. Hussain, T.; Kotnis A; Sarin R; Mulherkar, R., Establishment and characterization of
lymphoblastoid cell lines from patients with Multiple Primary Neoplasms in the upper aerodigestive
tract and healthy individuals. Indian J Med Res 2011. [In press]
64. Mohyuddin, A.; Ayub, Q.; Siddiqi, S.; Carvalho-Silva, D. R.; Mazhar, K.; Rehman, S.; Firasat, S.;
Dar, A.; Tyler-Smith, C.; Mehdi, S. Q., Genetic instability in EBV-transformed lymphoblastoid
cell lines. Biochim Biophys Acta 2004, 1670, (1), 81-3.
65. Fingeroth, J. D.; Weis, J. J.; Tedder, T. F.; Strominger, J. L.; Biro, P. A.; Fearon, D. T., Epstein-
Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A
1984, 81, (14), 4510-4.
66. Young, L. S.; Rickinson, A. B., Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4, (10),
757-68.
67. Cahir McFarland, E. D.; Izumi, K. M.; Mosialos, G., Epstein-barr virus transformation:
involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 1999,
18, (49), 6959-64.
68. Wang, D.; Liebowitz, D.; Wang, F.; Gregory, C.; Rickinson, A.; Larson, R.; Springer, T.; Kieff,
E., Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte
phenotype: deletion of the amino terminus abolishes activity. J Virol 1988, 62, (11), 4173-84.
69. Sugimoto, M.; Tahara, H.; Ide, T.; Furuichi, Y., Steps involved in immortalization and
tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer
Res 2004, 64, (10), 3361-4.
70. Kassauei, K.; Habbe, N.; Mullendore, M. E.; Karikari, C. A.; Maitra, A.; Feldmann, G.,
Mitochondrial DNA mutations in pancreatic cancer. Int J Gastrointest Cancer 2006, 37, (2-3), 57-
64.
71. Sandoval, N.; Platzer, M.; Rosenthal, A.; Dork, T.; Bendix, R.; Skawran, B.; Stuhrmann, M.;
Wegner, R. D.; Sperling, K.; Banin, S.; Shiloh, Y.; Baumer, A.; Bernthaler, U.; Sennefelder, H.;
Brohm, M.; Weber, B. H.; Schindler, D., Characterization of ATM gene mutations in 66 ataxia
telangiectasia families. Hum Mol Genet 1999, 8, (1), 69-79.
72. Cloos, J.; de Boer, W. P.; Snel, M. H.; van den Ijssel, P.; Ylstra, B.; Leemans, C. R.; Brakenhoff,
R. H.; Braakhuis, B. J., Microarray analysis of bleomycin-exposed lymphoblastoid cells for
identifying cancer susceptibility genes. Mol Cancer Res 2006, 4, (2), 71-7.
73. Islaih, M.; Li, B.; Kadura, I. A.; Reid-Hubbard, J. L.; Deahl, J. T.; Altizer, J. L.; Watson, D. E.;
Newton, R. K., Comparison of gene expression changes induced in mouse and human cells treated
with direct-acting mutagens. Environ Mol Mutagen 2004, 44, (5), 401-19.
74. Toda, T.; Sugimoto, M., Proteome analysis of Epstein-Barr virus-transformed B-lymphoblasts and
the proteome database. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 787, (1), 197-206.
75. Dirksen, E. H.; Cloos, J.; Braakhuis, B. J.; Brakenhoff, R. H.; Heck, A. J.; Slijper, M., Human
lymphoblastoid proteome analysis reveals a role for the inhibitor of acetyltransferases complex in
DNA double-strand break response. Cancer Res 2006, 66, (3), 1473-80.
152